Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T16:19:09.491Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum Vitamin-B12 Levels in Psychiatric Patients on Long-Term Psychotropic Drug Therapy

Published online by Cambridge University Press:  29 January 2018

James G. Henderson  and
Audrey A. Dawson
James G. Henderson
Affiliation:
Ross Clinic, Aberdeen
Audrey A. Dawson
Affiliation:
Department of Medicine, University of Aberdeen
Get access Rights & Permissions [Opens in a new window]

Extract

Recently much interest has been shown in the screening of populations for the presence of disease, either latent or overt (Wilson and Junger, 1968). In psychiatric practice the importance has been recorded of screening patients for the presence of avitaminosis B12 as a possible cause of psychiatric abnormality (Henderson et al 1966). Several methods of estimating serum vitamin-B12 levels have been evaluated, but the microbiological assay remains the most suitable method for use in a routine laboratory.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 116 , Issue 533 , April 1970 , pp. 439 - 442
Copyright
Copyright © Royal College of Psychiatrists, 1970 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baldwin, J. A., Innes, G., Millar, W. M., Sharp, G. A., and Dorricott, N. (1965). ‘A psychiatric ease register in North-East Scotland.’ Brit. J. prev. soc. Med., 19, 38–42.Google Scholar
Beck, J. Swanson, Dawson, A. A., Henderson, J. G., and Strachan, R. W. (1969). ‘Economic and laboratory considerations in screening for vitamin-B12 deficiency in psychiatric practice.’ J., clin. Path., 22, 317–20.Google Scholar
Edwin, E., Holten, K., Norum, K. R., Schrumpf, A., and Skaug, O. E. (1965). ‘Vitamin-B12 hypo- vitaminosis in mental diseases.’ Acta med. Scand., 177, 689–99.Google Scholar
Forshaw, J., and Harwood, L. (1966). ‘Serum vitamin-B12 and chlorpromazine.’ Lancet, ii, 602.Google Scholar
Henderson, J. G., Strachan, R. W., Beck, J. Swanson, , Dawson, A. A., and Daniel, M. (1966). ‘The anti-gastric-antibody test as a screening procedure for vitamin-B12 deficiency in psychiatric practice.’ Lancet, ii, 809–13.Google Scholar
Herbert, V., Gottleib, C. W., and Altschule, M. D. (1965). ‘Apparent low serum-vitamin-B12 levels associated with chlorpromazine.’ Lancet, ii, 1052–3.Google Scholar
Huang, C. L., and Kurland, A. A. (1961). ‘Chlorpro- mazine blood levels in psychotic patients.’ Arch. gen. Psychlat., 5, 509–11.Google Scholar
Wilson, J. M. G., and Junger, C. (1968). Principles and Practice of Screening for Disease. World Health Organization Publication.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.